Physician profile
Wayne Maben
NPI 1306899919
$18,759.13
in general payments reported to CMS, 2019-2025
20 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $51.19 · 2021: $52.24 · 2022: $81.33 · 2023: $17K · 2024: $127 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $17K · Food and Beverage: $406 · Long Term Medical Supply Or Device Loan: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $16,944.75 |
| Food and Beverage | $406.33 |
| Long Term Medical Supply Or Device Loan | $255.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,944.75 | 2023-2024 | |
| Medtronic Vascular, INC. | $848.44 | 2019 | |
| Integra Lifesciences Corporation | $272.77 | 2024-2025 | Micromatrix, Tcc-Ez |
| Smith+Nephew, INC. | $136.47 | 2024-2025 | Collagenase Santyl |
| Janssen Biotech, INC. | $125.30 | 2020-2025 | Erleada, Tremfya |
| Organogenesis INC. | $67.37 | 2025 | Apligraf, Puraply Wound Matrix |
| Intuitive Surgical, INC. | $60.12 | 2019 | |
| Antares Pharma, INC. | $38.21 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $30.66 | 2019 | |
| Organon LLC | $30.01 | 2023 | Renflexis |
| Covidien Lp | $28.96 | 2019 | |
| Heron Therapeutics, INC. | $27.62 | 2021-2023 | Zynrelef |
| Fresenius Kabi USA, LLC | $27.29 | 2023 | |
| Reprise Biomedical, INC. | $23.09 | 2025 | Miro3d |
| Mimedx Group, INC. | $21.21 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.76 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.03 | 2025 | Nuzyra |
| Olympus America INC. | $15.14 | 2023 | Olympus, Endoeye Flex 3d Deflectable Videoscope |
| Galderma Laboratories, L.P. | $13.92 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Maben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.